Company · CIK 1838716

# Genenta Science S.p.A.

| CIK | [1838716](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001838716) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | L6 |
| Business address | Italy |
| Listed | GNTA (Nasdaq) |
| First annual or quarterly report | 2022-05-02 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-271901 | Shelf Effective | 2023-05-12 | 2026-01-27 | 7 |
| 333-260923 | IPO Final prospectus | 2021-11-09 | 2021-12-15 | 5 |

## Filings

 14

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-01-27 | [424B5](https://www.sec.gov/Archives/edgar/data/1838716/000149315226003684/0001493152-26-003684-index.htm) Shelf takedown | 333-271901 | 0001493152-26-003684 |
| 2025-10-28 | [424B5](https://www.sec.gov/Archives/edgar/data/1838716/000149315225019853/0001493152-25-019853-index.htm) Shelf takedown | 333-271901 | 0001493152-25-019853 |
| 2025-03-28 | [424B5](https://www.sec.gov/Archives/edgar/data/1838716/000164117225001211/0001641172-25-001211-index.htm) Shelf takedown | 333-271901 | 0001641172-25-001211 |
| 2024-12-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1838716/000149315224051048/0001493152-24-051048-index.htm) Shelf takedown | 333-271901 | 0001493152-24-051048 |
| 2024-04-26 | [424B5](https://www.sec.gov/Archives/edgar/data/1838716/000149315224016707/0001493152-24-016707-index.htm) Shelf takedown | 333-271901 | 0001493152-24-016707 |
| 2023-05-24 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1838716/999999999523001524/9999999995-23-001524-index.htm) Declared effective | 333-271901 | 9999999995-23-001524 |
| 2023-05-12 | [F-3](https://www.sec.gov/Archives/edgar/data/1838716/000149315223016736/0001493152-23-016736-index.htm) Shelf registered | 333-271901 | 0001493152-23-016736 |
| 2021-12-15 | [424B1](https://www.sec.gov/Archives/edgar/data/1838716/000149315221031512/0001493152-21-031512-index.htm) Final prospectus | 333-261653 | 0001493152-21-031512 |
| 2021-12-15 | [424B1](https://www.sec.gov/Archives/edgar/data/1838716/000149315221031510/0001493152-21-031510-index.htm) Final prospectus | 333-260923 | 0001493152-21-031510 |
| 2021-12-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1838716/999999999521004680/9999999995-21-004680-index.htm) Declared effective | 333-260923 | 9999999995-21-004680 |
| 2021-12-07 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1838716/000149315221030643/0001493152-21-030643-index.htm) Amendment | 333-260923 | 0001493152-21-030643 |
| 2021-11-24 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1838716/000149315221029876/0001493152-21-029876-index.htm) Amendment | 333-260923 | 0001493152-21-029876 |
| 2021-11-09 | [F-1](https://www.sec.gov/Archives/edgar/data/1838716/000149315221027683/0001493152-21-027683-index.htm) Registration filed | 333-260923 | 0001493152-21-027683 |
| 2021-03-01 | [DRS](https://www.sec.gov/Archives/edgar/data/1838716/000149315221005022/0001493152-21-005022-index.htm) Draft made public | 377-04327 | 0001493152-21-005022 |

[All filings of this company](https://equitycapital.markets/filings?cik=1838716) · [CSV](https://equitycapital.markets/filings.csv?cik=1838716)

---
Source page: https://equitycapital.markets/company/1838716 · Data: U.S. SEC EDGAR · CC BY 4.0